International Medical Center of Biomaterials Processing and Cryostorage Past Earnings Performance
Past criteria checks 5/6
International Medical Center of Biomaterials Processing and Cryostorage has been growing earnings at an average annual rate of 0.7%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 5.5% per year. International Medical Center of Biomaterials Processing and Cryostorage's return on equity is 54.6%, and it has net margins of 48.7%.
Key information
0.7%
Earnings growth rate
-4.4%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 5.5% |
| Return on equity | 54.6% |
| Net Margin | 48.7% |
| Last Earnings Update | 30 Jun 2022 |
Revenue & Expenses Breakdown
How International Medical Center of Biomaterials Processing and Cryostorage makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 261 | 127 | 73 | 0 |
| 31 Mar 22 | 267 | 134 | 70 | 0 |
| 31 Dec 21 | 266 | 137 | 71 | 0 |
| 30 Sep 21 | 272 | 144 | 71 | 0 |
| 30 Jun 21 | 250 | 123 | 57 | 0 |
| 31 Mar 21 | 252 | 133 | 58 | 0 |
| 31 Dec 20 | 243 | 123 | 54 | 0 |
| 30 Sep 20 | 229 | 100 | 65 | 0 |
| 31 Mar 20 | 237 | 112 | 70 | 0 |
| 31 Dec 19 | 239 | 119 | 69 | 0 |
| 30 Sep 19 | 235 | 115 | 74 | 0 |
| 31 Mar 19 | 233 | 127 | 58 | 0 |
| 31 Dec 18 | 243 | 142 | 53 | 0 |
| 31 Dec 17 | 212 | 133 | 46 | 0 |
| 31 Dec 16 | 130 | 58 | 20 | 0 |
| 31 Dec 15 | 22 | 7 | 7 | 0 |
Quality Earnings: GEMA has high quality earnings.
Growing Profit Margin: GEMA's current net profit margins (48.7%) are lower than last year (49.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GEMA's earnings have grown by 0.7% per year over the past 5 years.
Accelerating Growth: GEMA's earnings growth over the past year (3%) exceeds its 5-year average (0.7% per year).
Earnings vs Industry: GEMA earnings growth over the past year (3%) exceeded the Healthcare industry -5.3%.
Return on Equity
High ROE: GEMA's Return on Equity (54.6%) is considered outstanding.